LRCX Surges 28% In A Single Month: Where Does It Rank Among Competitors?
Here is how Lam Research (LRCX) stacks up against its peers in size, valuation, growth and margin.
- LRCX’s operating margin of 32.0% is high, higher than most peers though lower than KLAC (41.2%).
- LRCX’s revenue growth of 23.7% in the last 12 months is strong, outpacing AMAT, ADI, ICHR but lagging KLAC.
- LRCX gained 65.6% in the past year and trades at a PE of 30.2, outperforming its peers.
As a quick background, Lam Research provides semiconductor processing equipment and services for integrated circuit fabrication to customers worldwide, including the US, China, Europe, Japan, Korea, Southeast Asia, and Taiwan.
| LRCX | AMAT | ADI | KLAC | ICHR | |
|---|---|---|---|---|---|
| Market Cap ($ Bil) | 161.7 | 151.7 | 121.3 | 138.0 | 0.6 |
| Revenue ($ Bil) | 18.4 | 28.6 | 10.4 | 12.2 | 0.9 |
| PE Ratio | 30.2 | 22.2 | 62.0 | 34.0 | -30.5 |
| LTM Revenue Growth | 23.7% | 6.6% | 7.1% | 23.9% | 15.4% |
| LTM Operating Margin | 32.0% | 30.1% | 25.3% | 41.2% | -0.8% |
| LTM FCF Margin | 29.4% | 20.4% | 35.4% | 30.8% | -2.0% |
| 12M Market Return | 65.6% | -0.0% | 10.0% | 39.0% | -32.9% |
Why does this matter? LRCX just went up 28% in a month – peer comparison puts stock performance, valuation, and financials in context – highlighting whether it is truly outperforming, lagging behind, and above all – can this continue? Read Buy or Sell LRCX Stock to see if Lam Research holds up as a quality investment. Furthermore, there is always a risk of fall after a strong rally – see how the stock has dipped and recovered in the past through LRCX Dip Buyer Analysis lens.
While peer comparison is critical Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risks while giving upside exposure.
- Palantir At 80x Earnings: What Revenue Growth Rate Justifies The Valuation?
- Should You Pay Attention To Chevron Stock’s Momentum?
- What Is Happening With Caterpillar Stock?
- What Can Trigger Microsoft Stock’s Slide?
- Is Microsoft Stock A Trap Or A Missed Opportunity?
- Earn 9.6% Today or Buy BSX 30% Cheaper – It’s a Win-Win
Revenue Growth Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| LRCX | 23.7% | 23.7% | -14.5% | 1.2% | |
| AMAT | 6.6% | – | 2.5% | 2.8% | 11.8% |
| ADI | 7.1% | – | -23.4% | 2.4% | 64.2% |
| KLAC | 23.9% | 23.9% | -6.5% | 13.9% | |
| ICHR | 15.4% | – | 4.7% | -36.6% | 16.7% |
Operating Margin Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| LRCX | 32.0% | 32.0% | 28.7% | 29.9% | |
| AMAT | 30.1% | – | 28.9% | 28.9% | 30.2% |
| ADI | 25.3% | – | 22.0% | 32.4% | 29.6% |
| KLAC | 41.2% | 41.2% | 37.1% | 38.1% | |
| ICHR | -0.8% | – | -0.9% | -1.3% | 6.7% |
PE Ratio Comparison
| LTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| LRCX | 30.2 | 17.3 | 26.9 | 12.6 | |
| AMAT | 22.2 | – | 18.7 | 19.9 | 13.0 |
| ADI | 62.0 | – | 64.5 | 30.1 | 31.0 |
| KLAC | 34.0 | 20.6 | 28.5 | 15.5 | |
| ICHR | -30.5 | – | -50.7 | -22.8 | 10.6 |
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.